Blog

Toronto, Ontario – April 19, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it will release financial results for the first quarter of 2017 after the close of trading on … Continue reading “NOVADAQ to Report First Quarter 2017 Financial Results on May 3, 2017”

Toronto, Ontario – February 28, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries today reported financial results for the three months and full year ended December 31, 2016. Unless otherwise indicated, all dollar … Continue reading “NOVADAQ Announces Fourth Quarter and Full Year 2016 Financial Results”

DermACELL receives coverage from Cigna

Posted on February 2, 2017

LifeNet Health is proud that Cigna Health Insurance is now covering Dermacell when used in association with covered medically necessary breast reconstruction procedures. Dermacell AWM has also been approved for coverage as medically necessary for diabetic foot ulcers when the following criteria are met: partial- or full-thickness diabetic foot ulcers of greater than four weeks … Continue reading “DermACELL receives coverage from Cigna”

Toronto, Ontario – February 15, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it will release financial results for the fourth quarter and full year 2016 after the close of … Continue reading “NOVADAQ TO REPORT FOURTH QUARTER AND FULL YEAR 2016 FINANCIAL RESULTS ON FEBRUARY 28, 2017”

Toronto, Ontario – February 8, 2017 – NOVADAQ Technologies Inc. (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced that it plans to participate in two upcoming investor conferences. Rick Mangat, President and Chief Executive Officer, is … Continue reading “NOVADAQ ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES”

Secures up to $60 million in financing from Midcap Financial Toronto, Ontario – January 10, 2017 – NOVADAQ Technologies Inc (NASDAQ:NVDQ; TSX:NDQ), the leading provider of proven comprehensive fluorescence imaging solutions that improve clinical outcomes and reduce healthcare costs in minimally invasive and open surgeries, today announced preliminary financial results for fourth quarter and full year 2016 … Continue reading “NOVADAQ Announces Preliminary Unaudited Fourth Quarter 2016 Revenue and Issues 2017 Revenue guidance”

Toronto, Ontario – January 4, 2017 – NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Lisa Colleran has been appointed to its board of directors, effective immediately. Lisa Colleran is a veteran in … Continue reading “NOVADAQ appoints Lisa Colleran to its board of directors”

The PINPOINT Endoscopic Fluorescence Imaging System was recently featured in the AIS Channel’s live streaming international consensus on rectal cancer surgery. The London-based event was broadcast to showcase and discuss the four common surgical strategies for rectal cancer. World renowned experts presented during the event and four live rectal cancer surgeries were performed simultaneously in … Continue reading “PINPOINT Utilized During International Symposium on the Future of Rectal Cancer Surgery”

NOVADAQ Technologies Inc. (“NOVADAQ” or the “Company”) (NASDAQ:NVDQ; TSX:NDQ), the leading developer and provider of clinically relevant, fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today that Rick Mangat, President and Chief Executive Officer, will present on the Company’s business at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, … Continue reading “NOVADAQ to Present at the 35th Annual J.P. Morgan Healthcare Conference”

Patients reconstructed with DermACELL as compared to AlloDerm RTU have significantly decreased number of days to drain removal and ‘red breast’ syndrome. Rates of other complications including seroma, infection, flap necrosis and explantation were equivalent. An article recently accepted and made available online by Plastic and Reconstructive Surgery compared the clinical outcomes between two acellular … Continue reading “Comparison of Different Acellular Dermal Matrices (ADM) in Breast Reconstruction: The 50/50 Study”